Countries

PRESS RELEASE

Contact:
Barry Murov, 636-733-1303
barrym@relivinc.com
 

 

Reliv International’s GlucAffect™ Proven Effective in Clinical Study

 

Study Shows GlucAffect Reduces Blood Glucose Levels and Promotes Weight Loss


CHESTERFIELD, Mo., July 16, 2009 – A clinical study published in the journal Phytotherapy Research found that GlucAffect™, a nutritional supplement developed by Reliv International, Inc. (NASDAQ:RELV), significantly reduced blood glucose levels and helped control weight in study participants.

 

The study included 50 overweight individuals who had pre-diabetic glucose levels prior to the study. Subjects taking GlucAffect, a powdered product mixed with water or other liquids, lowered their fasting blood glucose by an average of 30 percent and they lost an average of 16 pounds. Subjects in the control group reported a marginal decline in blood glucose levels and no significant weight loss.

 

The study was conducted at Gabriele D’Annunzio University in Chieti-Pescara, Italy.

 

“The people in the GlucAffect group achieved statistically significant lower blood sugar levels as well as significant weight loss compared to both their own baseline starting point and to the results of the people in the placebo group,” said Dr. Carl Hastings, Reliv’s vice chairman and chief scientific officer, who is a Ph.D. in food science. “GlucAffect enabled subjects to achieve healthy weight and blood sugar levels after eight weeks,” Hastings added.

 

 

Learn to live better

 

Sign up to receive Reliv's Healthy Living Tips and Science & Health Today free via email.

Email Address:

Submit

Copyright © 2012 International. All rights reserved.
136 Chesterfield Ind. Blvd., Chesterfield, MO 63005
Toll free: 800.735.4887
Phone 636.537.9715 | Fax 636.537.9753
Contact Us | Privacy Policy | Investor Relations

Anti-aging supplement
Blood sugar management
Digestive health
Healthy energy shot
Heart health
Joint health

LunaRich Soy Powder
Pycnogenol
Reliv Blog
Soy supplements
Team Reliv
Weight loss shake